Juan Diocares
Gastroenterology · Temple, TXNPI 1568873651
Payments from drug & device makers
Across 263 payments — averaging $19.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Boston Scientific$513
- Johnson & Johnson$374
- Gilead$302
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$295
- Janssen Scientific Affairs, LLC$235
- plus $2K from 26 others
What the payments were for
- Travel & lodging$3777%
- Food & beverage$4,80693%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 118 | $1,898 |
| Boston Scientific | 4 | $513 |
| Johnson & Johnson | 21 | $374 |
| Gilead | 16 | $302 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $295 |
| Janssen Scientific Affairs, LLC | 2 | $235 |
| Lilly USA, LLC | 7 | $160 |
| Bristol Myers Squibb | 9 | $141 |
| Intercept Pharmaceuticals, Inc. | 9 | $137 |
| Regeneron Healthcare Solutions, Inc. | 4 | $112 |
| Aimmune Therapeutics, Inc. | 6 | $107 |
| Sanofi | 4 | $105 |
| Nestle Healthcare Nutrition Inc. | 5 | $103 |
| QOL Medical, LLC | 4 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $74 |
| Ferring Pharmaceuticals Inc. | 4 | $59 |
| Ironwood Pharmaceuticals, Inc | 3 | $57 |
| Ardelyx, Inc. | 2 | $52 |
| Pfizer | 3 | $51 |
| Madrigal Pharmaceuticals | 2 | $46 |
| AMAG Pharmaceuticals, Inc. | 2 | $39 |
| Vivus LLC | 2 | $34 |
| Merck | 2 | $31 |
| Amgen | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Celltrion USA Inc. | 2 | $27 |
| Braintree Laboratories, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Micro-tech Endoscopy USA, Inc. | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $14 |
| Endogastric Solutions, Inc | 1 | $4 |
| Gastrogpo, LLC | 3 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXALT Model D$484
- Tremfya$147
- STELARA$147
How this compares
$5,183 in reported general payments places this provider in the 55th percentile of 1,350 gastroenterology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 21 | $90,244 |
| LinzessLinaclotide | 24 | $23,566 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 114 | $17,907 |
| Sucralfate | 45 | $4,752 |
| Pantoprazole Sodium | 280 | $3,181 |
| Ursodiol | 12 | $1,054 |
| Omeprazole | 47 | $971 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 35 | $782 |
| Esomeprazole Magnesium | 16 | $732 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 34 | $590 |
| Famotidine | 29 | $482 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 27 | $386 |
| Ondansetron OdtOndansetron | 26 | $292 |
| Metronidazole | 14 | $211 |
| Dicyclomine Hcl | 27 | $184 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $1,898 | $113,80945 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $59 | $17,907114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,350 gastroenterology providers in Texas.
Other gastroenterology in Temple
- Christopher JohnsonTemple$632K
- Eric LawitzSan Antonio$59.5M
- George DuvallTyler$17.5M
- John FordtranDallas$9.9M
- Timothy RitterSouthlake$7.7M
- Parvez MantryDallas$6.4M
- Mazen NoureddinHouston$6.1M
- Nadege GunnWaco$5.7M
- Michael BrownDallas$5.5M
- James MaherHouston$5.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.